3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
10
Fallopian Tube Neoplasms
10
Breast Neoplasms
7
Endometrial Neoplasms
5
Neoplasms
4
Triple Negative Breast Neoplasms
3
Prostatic Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Urinary Bladder Neoplasms
2
Pheochromocytoma
2
Paraganglioma
2
Osteosarcoma
2
Neuroendocrine Tumors
2
Neuroblastoma
2
Metastatic Castration-resistant Prostate Cancer
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Glioma
2
Glioblastoma
2
Ependymoma
2
Cholangiocarcinoma
2
Xanthogranuloma, Juvenile
1
Wilms Tumor
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Sarcoma, Synovial
1
Sarcoma, Ewing
1
Interventions
durvalumab
1
Immunotherapy
1
Bevacizumab
1
ALT-803
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Glandular and Epithelial
×
olaparib
×
30 days
×
Clear all
No trials found.